Related Experiment Video
Updated: Jun 19, 2026

Mouse In Vivo Placental Targeted CRISPR Manipulation
Published on: April 14, 2023
Placenta-specific gene activation and inactivation using integrase-defective lentiviral vectors with the Cre/LoxP
Yuka Morioka1, Ayako Isotani, Robert G Oshima
1Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Abstract:
Transgenic and knockout studies have advanced our understanding of the genetic control of embryonic development over the past decades. However, interpretation of the phenotype of mutant mice is potentially complicated, since the commonly used knockout approach modifies both the fetal and placental genome. To circumvent this problem, we previously developed a placenta-specific gene manipulation system by lentiviral vector transduction of embryos at the blastocyst stage. In the present study, by combination with the Cre/LoxP system, we successfully demonstrate placenta-specific gene activation and inactivation in EGFP reporter mice and Ets2 floxed mice, respectively. Transient expression using integrase-defective lentiviral (IDLV) vectors diminished the toxic effect of Cre expression and solved the dilemma of mosaic recombination with lower concentrations and toxic effects with higher concentrations of Cre recombinase. We also show that placenta-specific Ets2 disruption causes embryonic lethality and reconfirmed the critical role of Ets2 during placentation. This technology facilitates both gain and loss of gene function analyses in placental development during pregnancy. Since IDLV vectors can efficiently transduce a variety of cell types similarly to wild-type vectors, our IDLV-Cre strategy is potentially useful for a wide range of applications.
Insights
Researchers developed a placenta-specific gene editing system using lentiviral vectors. This method allows precise genetic modification in the placenta, revealing the critical role of Ets2 in embryonic development and preventing lethality.
Area of Science:
- Developmental Biology
- Genetics
- Molecular Biology
Background:
- Traditional knockout studies complicate phenotype interpretation due to simultaneous modification of fetal and placental genomes.
- A placenta-specific gene manipulation system was previously developed using lentiviral vector transduction of blastocysts.
Purpose of the Study:
- To demonstrate placenta-specific gene activation and inactivation using the Cre/LoxP system combined with lentiviral vectors.
- To evaluate the utility of integrase-defective lentiviral (IDLV) vectors for transient gene expression and recombination in placental development.
- To investigate the role of Ets2 in placentation through placenta-specific gene disruption.
Main Methods:
- Combination of the Cre/LoxP system with lentiviral vector transduction of embryos at the blastocyst stage.
- Utilized integrase-defective lentiviral (IDLV) vectors for transient expression of Cre recombinase.
- Applied the system to EGFP reporter mice for gene activation and Ets2 floxed mice for gene inactivation.
Main Results:
- Successfully demonstrated placenta-specific gene activation and inactivation in reporter and Ets2 floxed mice.
- Transient Cre expression via IDLV vectors mitigated toxicity and mosaic recombination issues.
- Placenta-specific disruption of Ets2 resulted in embryonic lethality, confirming its crucial role in placentation.
Conclusions:
- The developed IDLV-Cre strategy enables precise, placenta-specific gene function analysis (gain and loss) during pregnancy.
- This technology overcomes limitations of traditional knockout approaches for studying placental development.
- The IDLV-Cre system offers a versatile tool for various applications in placental biology and beyond.
More Related Videos
10:42A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
Published on: December 12, 2017
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019